Covid-19 Vaccine
-
{
- All
- News
- Videos
- Web Stories
-
India's Pandemic Preparedness: Which Healthcare Areas Need Urgent Attention?
India has made progress in healthcare, but Covid-19 showed that more needs to be done
-
Oxford Scientists Are Developing First-Ever Vaccine For Rare Bundibugyo Ebola Strain
Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says
-
Are Nasal Vaccines The Future? Scientists Explain The Rise of Needle-Free Immunisation
Nasal vaccines represent a promising shift in how we prevent infectious diseases. By building immunity at the body's first line of defence, they could stop infections before they begin, reduce transmission, and complement traditional vaccines.
-
The Big Catch-Up Initiative Delivers 100 Million Childhood Vaccines Globally, WHO Confirms
The World Health Organization's Big Catch-Up initiative has delivered over 100 million vaccine doses to children worldwide, targeting those missed during the COVID-19 pandemic and helping restore global immunisation coverage.
-
Covid Vaccine Claims Go Viral After Elon Musk's Comments; Experts Explain What The Evidence Shows
Covid-19 vaccine claims made by Elon Musk have recently shifted public discourse on the vaccine's efficacy. Here is what medical health authorities, doctors, and scientific data indicate about the efficacy of the COVID-19 vaccine.
-
"Felt I Was Dying": Musk Backs Claim Covid Jab Killed Thousands In Germany
Dr Helmut Sterz, a former Pfizer toxicologist, raised concerns about how Pfizer’s Comornaty mRNA vaccine was developed and tested in a quick manner.
-
Cicada COVID Variant BA. 3.2: Why Children Are 5 Times More Likely To Get Infected And Tips To Safeguard Them
The new cicada COVID variant BA.3.2 can infect children 5 times more than the Omicron variant. This is why you need to get your children a booster dose and follow the established protocol to safeguard them.
-
Cicada Vs Previous Omicron Strains: What's Truly Different Between The Covid-19 Variants?
Unlike early Omicron strains such as BA.1 and BA.2, Cicada has more changes that might help it dodge immunity from vaccines or past infections.
-
Covid-19 Cicada Variant: Can Current Vaccines Protect Against BA.3.2 Subvariant?
The BA.3.2 sub-variant was first detected in South Africa in late 2024. The variant has been detected in at least 23 countries worldwide.
-
New Cicada Covid-19 Variant BA.3.2 Detected In The US: Key Facts, Symptoms, Risk Factors Explained
A new Covid-19 subvariant, BA.3.2, nicknamed Cicada, is being tracked in the US and other countries. Experts say it carries multiple mutations, may evade immunity, but currently shows no clear rise in severe illness.
-
India's Universal Immunisation Programme Sets Global Benchmark
From eradicating smallpox in 1977 to eliminating polio and neonatal tetanus, administering 200 crore COVID-19 doses, and now pursuing Measles-Rubella elimination — India's immunisation journey is one of verified, milestone-
-
Severe COVID, Flu Infections Linked To Higher Lung Cancer Risk, Finds Study
A recent study has found that severe cases COVID-19 or influenza can leave lasting changes in the lungs that increase the risk of lung cancer years later. The study was conducted by researchers from the University of Virginia Health System.
-
Form Compensation Policy For Harm From Covid Shots: Supreme Court To Centre
The Supreme Court on Tuesday directed the Centre to formulate a no-fault compensation policy for people who suffered serious adverse events following Covid-19 vaccination.
-
Once A US CDC Critic, Jay Bhattacharya To Lead Agency On Acting Basis
The Donald Trump administration has appointed Jay Bhattacharya to lead the Centers for Disease Control (CDC) and Prevention on an acting basis, The New York Timesreported.
-
Women And Elderly More Likely To Be Covid-19 Vaccine-Hesitant: Lancet Study
Women and the elderly are more likely to be vaccine-hesitant, according to a study on Tuesday, which analysed data from more than 1.1 million people.
-
India's Pandemic Preparedness: Which Healthcare Areas Need Urgent Attention?
India has made progress in healthcare, but Covid-19 showed that more needs to be done
-
Oxford Scientists Are Developing First-Ever Vaccine For Rare Bundibugyo Ebola Strain
Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says
-
Are Nasal Vaccines The Future? Scientists Explain The Rise of Needle-Free Immunisation
Nasal vaccines represent a promising shift in how we prevent infectious diseases. By building immunity at the body's first line of defence, they could stop infections before they begin, reduce transmission, and complement traditional vaccines.
-
The Big Catch-Up Initiative Delivers 100 Million Childhood Vaccines Globally, WHO Confirms
The World Health Organization's Big Catch-Up initiative has delivered over 100 million vaccine doses to children worldwide, targeting those missed during the COVID-19 pandemic and helping restore global immunisation coverage.
-
Covid Vaccine Claims Go Viral After Elon Musk's Comments; Experts Explain What The Evidence Shows
Covid-19 vaccine claims made by Elon Musk have recently shifted public discourse on the vaccine's efficacy. Here is what medical health authorities, doctors, and scientific data indicate about the efficacy of the COVID-19 vaccine.
-
"Felt I Was Dying": Musk Backs Claim Covid Jab Killed Thousands In Germany
Dr Helmut Sterz, a former Pfizer toxicologist, raised concerns about how Pfizer’s Comornaty mRNA vaccine was developed and tested in a quick manner.
-
Cicada COVID Variant BA. 3.2: Why Children Are 5 Times More Likely To Get Infected And Tips To Safeguard Them
The new cicada COVID variant BA.3.2 can infect children 5 times more than the Omicron variant. This is why you need to get your children a booster dose and follow the established protocol to safeguard them.
-
Cicada Vs Previous Omicron Strains: What's Truly Different Between The Covid-19 Variants?
Unlike early Omicron strains such as BA.1 and BA.2, Cicada has more changes that might help it dodge immunity from vaccines or past infections.
-
Covid-19 Cicada Variant: Can Current Vaccines Protect Against BA.3.2 Subvariant?
The BA.3.2 sub-variant was first detected in South Africa in late 2024. The variant has been detected in at least 23 countries worldwide.
-
New Cicada Covid-19 Variant BA.3.2 Detected In The US: Key Facts, Symptoms, Risk Factors Explained
A new Covid-19 subvariant, BA.3.2, nicknamed Cicada, is being tracked in the US and other countries. Experts say it carries multiple mutations, may evade immunity, but currently shows no clear rise in severe illness.
-
India's Universal Immunisation Programme Sets Global Benchmark
From eradicating smallpox in 1977 to eliminating polio and neonatal tetanus, administering 200 crore COVID-19 doses, and now pursuing Measles-Rubella elimination — India's immunisation journey is one of verified, milestone-
-
Severe COVID, Flu Infections Linked To Higher Lung Cancer Risk, Finds Study
A recent study has found that severe cases COVID-19 or influenza can leave lasting changes in the lungs that increase the risk of lung cancer years later. The study was conducted by researchers from the University of Virginia Health System.
-
Form Compensation Policy For Harm From Covid Shots: Supreme Court To Centre
The Supreme Court on Tuesday directed the Centre to formulate a no-fault compensation policy for people who suffered serious adverse events following Covid-19 vaccination.
-
Once A US CDC Critic, Jay Bhattacharya To Lead Agency On Acting Basis
The Donald Trump administration has appointed Jay Bhattacharya to lead the Centers for Disease Control (CDC) and Prevention on an acting basis, The New York Timesreported.
-
Women And Elderly More Likely To Be Covid-19 Vaccine-Hesitant: Lancet Study
Women and the elderly are more likely to be vaccine-hesitant, according to a study on Tuesday, which analysed data from more than 1.1 million people.
